Literature DB >> 4593239

Demonstration of a blocking factor in the plasma and spinal fluid of patients with subacute sclerosing panencephalitis. I. Partial characterization.

A Ahmed, D M Strong, K W Sell, G B Thurman, R C Knudsen, R Wistar, W R Grace.   

Abstract

Conflicting reports on the immune responsiveness of patients with subacute sclerosing panencephalitis (SSPE) have been reported. This report shows that the leucocytes from four SSPE patients exhibited strong sensitivity to both measles and SSPE virus preparations as measured by the macrophage migration inhibition test, mixed lymphocyte virus infected cell culture test, and the lymphotoxin assay. Earlier suggestions that a factor may be operating to suppress cellular reactivity are confirmed by the demonstration that the response of lymphocytes from SSPE patients could be blocked by the addition of SSPE spinal fluid or plasma. It was determined that the blocking factor was stable at -20 degrees C, heat labile at 56 degrees C for 30 minutes, trypsin and neuraminadase sensitive, and had a mol wt greater than 150,000 as determined by Sephadex G-200 gel chromatography. The blocking factor appeared to be specific for SSPE virus and did not block the response of lymphocytes to nonspecific mitogenic agents and other viral and bacterial agents.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4593239      PMCID: PMC2139563          DOI: 10.1084/jem.139.4.902

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

1.  Measles-virus antibody and antigen in subacute sclerosing panencephalitis.

Authors:  J H Connolly; I V Allen; L J Hurwitz; J H Millar
Journal:  Lancet       Date:  1967-03-11       Impact factor: 79.321

2.  Measles and subacute sclerosing panencephalitis.

Authors:  O Kolar
Journal:  Lancet       Date:  1968-12-07       Impact factor: 79.321

3.  Lymphocyte transformation in multiple sclerosis. Inhibition of unstimulated thymidine uptake by a serum factor.

Authors:  M Knowles; D Hughes; E A Caspary; E J Field
Journal:  Lancet       Date:  1968-12-07       Impact factor: 79.321

4.  Transformation of human lymphocytes: inhibition by homologous alpha globulin.

Authors:  S R Cooperband; H Bondevik; K Schmid; J A Mannick
Journal:  Science       Date:  1968-03-15       Impact factor: 47.728

5.  Immunhistological, microscopical and neurochemical studies on encephalitides. 3. Subacute progressive panencephalitis. Virological and immunhistological studies.

Authors:  V ter Muelen; G Enders-Ruckle; D Müller; G Joppich
Journal:  Acta Neuropathol       Date:  1969       Impact factor: 17.088

6.  Transmission of an encephalitogenic agent from brains of patients with subacute sclerosing panencephalitis to ferrets. Preliminary report.

Authors:  M Katz; L B Rorke; W S Masland; H Koprowski; S H Tucker
Journal:  N Engl J Med       Date:  1968-10-10       Impact factor: 91.245

7.  Inhibition of macrophage migration by a skin-reactive polysaccharide from BCG culture filtrates.

Authors:  H P Godfrey; H Baer; S D Chaparas
Journal:  J Immunol       Date:  1969-06       Impact factor: 5.422

8.  Studies of delayed dermal hypersensitivity in patients with subacute sclerosing panencephalitis.

Authors:  J T Jabbour; J A Roane; J L Sever
Journal:  Neurology       Date:  1969-10       Impact factor: 9.910

9.  Lymphocyte in vitro cytotoxicity: mechanisms of immune and non-immune small lymphocyte mediated target L cell destruction.

Authors:  G A Granger; W P Kolb
Journal:  J Immunol       Date:  1968-07       Impact factor: 5.422

10.  Effect of plasma from patients with carcinoma on in vitro lymphocyte transformation.

Authors:  M Silk
Journal:  Cancer       Date:  1967-12       Impact factor: 6.860

View more
  18 in total

1.  Demonstration of T-cell and K-cell cytotoxicity against measles-infected cells in normal subjects, multiple sclerosis and subacute sclerosing panencephalitis.

Authors:  P W Ewan; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

Review 2.  Measles virus and its associated diseases.

Authors:  E M Morgan; F Rapp
Journal:  Bacteriol Rev       Date:  1977-09

3.  Immunological aspects of cryoprecipitates from the sera of chronic HBsAg carriers.

Authors:  M L Tiku; K R Beutner; P L Ogra
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

4.  Cellular immunity in subacute sclerosing panencephalitis.

Authors:  H Valdimarsson; G Agnarsdottir; P J Lachmann
Journal:  Proc R Soc Med       Date:  1974-11

5.  Cellular immunity in SSPE patients.

Authors:  H W Kreth; Y M Kaeckell; V ter Meulen
Journal:  Med Microbiol Immunol       Date:  1974       Impact factor: 3.402

6.  Effects of canine distemper virus infection on lymphoid function in vitro and in vivo.

Authors:  S Krakowka; G Cockerell; A Koestner
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

7.  Human T-cell heterogeneity as delineated with a specific human thymus lymphocyte antiserum. In vitro effects on mitogen response mixed leukocyte culture, cell-mediated lymphocytotoxicity, and lymphokine production.

Authors:  J N Woody; A Ahmed; R C Knudsen; D M Strong; K W Sell
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

8.  Cellular and humoral immunity in subacute sclerosing panencephalitis.

Authors:  S S Dhib-Jalbut; A M Abdelnoor; F S Haddad
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

9.  Prevalence of measles antibodies in patients with subacute sclerosing panencephalitis in Poland in the years 1971--1978.

Authors:  I Polna; J Wyszkowski; J Kulczycki; A Szcześniak; H Abramowicz
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

10.  Subacute sclerosing panencephalitis and multiple sclerosis: in vitro measles immunity and sensitization to myelin basic protein.

Authors:  W Sheremata; A Sazant; G Watters
Journal:  Can Med Assoc J       Date:  1978-03-04       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.